DongKoo Bio & Pharma becomes Qurient's largest shareholder through strategic investment
DongKoo Bio & Pharma, a Korean company known for its dermatological products, has announced a strategic investment of 10 billion won ($7.2 million) into Qurient, a local biotech, becoming its largest shareholder. Through this latest investment, DongKoo …